KCMF1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.319400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.257200E-01
Normal-vs-Stage2
8.906000E-01
Normal-vs-Stage3
5.331600E-01
Normal-vs-Stage4
2.918200E-01
Stage1-vs-Stage2
4.840600E-01
Stage1-vs-Stage3
7.599600E-01
Stage1-vs-Stage4
2.485400E-01
Stage2-vs-Stage3
3.325600E-01
Stage2-vs-Stage4
4.298000E-01
Stage3-vs-Stage4
1.941610E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.142200E-01
Normal-vs-AfricanAmerican
7.526800E-01
Normal-vs-Asian
6.627200E-01
Caucasian-vs-AfricanAmerican
6.267400E-01
Caucasian-vs-Asian
3.702400E-01
AfricanAmerican-vs-Asian
8.473800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.658800E-01
Normal-vs-Female
8.973800E-01
Male-vs-Female
7.075000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.361800E-01
Normal-vs-Age(41-60Yrs)
5.676800E-01
Normal-vs-Age(61-80Yrs)
8.942600E-01
Normal-vs-Age(81-100Yrs)
9.528200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.608500E-02
Age(21-40Yrs)-vs-Age(61-80Yrs)
2.653200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.009600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.184400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.408200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
8.655000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.547800E-01
Normal-vs-Daily Drinker
8.753400E-01
Normal-vs-Weekly Drinker
8.247600E-01
Normal-vs-Occasional Drinker
3.105400E-01
Normal-vs-Social Drinker
7.597800E-01
Non Drinker-vs-Daily Drinker
9.581200E-01
Non Drinker-vs-Weekly Drinker
9.170800E-01
Non Drinker-vs-Occasional Drinker
2.878100E-02
Non Drinker-vs-Social Drinker
3.733400E-01
Daily Drinker-vs-Weekly Drinker
8.880600E-01
Daily Drinker-vs-Occasional Drinker
4.205700E-02
Daily Drinker-vs-Social Drinker
4.213600E-01
Weekly Drinker-vs-Occasional Drinker
5.622200E-02
Weekly Drinker-vs-Social Drinker
4.040600E-01
Occasional Drinker-vs-Social Drinker
2.499000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.030800E-01
Normal-vs-Grade 2
1.865600E-02
Normal-vs-Grade 3
8.636400E-03
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.802000E-03
Grade 1-vs-Grade 3
3.228500E-04
Grade 1-vs-Grade 4
1.030800E-01
Grade 2-vs-Grade 3
1.588380E-01
Grade 2-vs-Grade 4
1.865600E-02
Grade 3-vs-Grade 4
8.636400E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
9.485200E-01
Normal-vs-NonDiabetic
9.653400E-01
Diabetic-vs-NonDiabetic
9.393000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.805000E-01
Normal-vs-NoPancreatitis
9.806000E-01
Pancreatitis-vs-NoPancreatitis
8.546400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.413200E-01
Normal-vs-N1
9.102800E-01
N0-vs-N1
8.542200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.272300E-02
Normal-vs-TP53-NonMutant
7.073800E-01
TP53-Mutant-vs-TP53-NonMutant
4.04480000000262E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
